REFERENCES
- Balfour D J. Neural mechanisms underlying nicotine dependence. Addiction 1994; 89(11)1419–1423
- Pomerleau O F. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med 1992; 93(1A)2S–7S
- Stead L F, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008, Accessed from http://www.ncbi.nlm.nih.gov/pubmed/18253970?ordinalpos=4&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
- Becker K M, Rose J E, Albino A P. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nicotine Tob Res 2008; 10(7)1139–1148
- Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004, Accessed from http://www.ncbi.nlm.nih.gov/pubmed/15266423?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
- Sonderskov J, Olsen J, Sabroe S, Meillier L, Overad K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol 1997; 145(4)309–318
- Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: Findings from the Cochrane Library. BMJ 2000; 321(7257)355–358
- Wallstrom M, Nilsson F, Hirsch J M. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 2000; 95(8)1161–1171
- Glover E D, Glover P N, Franzon M, Sullivan C R, Cerullo C C, Howell R M, Reyes G G, Nilson F, Hobbs G R. A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine Tob Res 2002; 4(4)441–450
- Woodruff S I, Conway T L, Edwards C C. Sociodemographic and smoking-related psychosocial predictors of smoking behavior change among high school smokers. Addict Behav 2008; 33(2)354–358
- Gourlay S G, Forbe S, Mamner T, Pethica D, McNeil J J. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309(6958)842–846
- Coleman T. Special groups of smokers. BMJ 2004; 328(7439)575–577
- Monso E, Campbell J, Tonnesen P, Gastavsson G, Moreva J. Sociodemographic predictors of success in smoking intervention. Tob Control 2001; 10(2)165–169
- Myung S K, Seo H G, Park S, Kim Y, Kim D J, Leedo H, et al. Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches. J Korean Med Sci 2007; 22(6)1065–1070
- Guo Song J Z-N, Sun H-Q, Niu G-S, Gao J-Y, Yang X-H, Zhou D-F. The smoking cessation efficacy of nicotine sublingual tablet: A double-blind, placebo controlled trail. Chin J Psychiatry 2006; 39(2)102–105
- Bolliger C T, Zellweger J P, Danielson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000; 321(7257)329–333
- Norregaard J, Tonnesen P, Petersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med 1993; 22(2)261–271
- D'Angelo M E, Reid R D, Brown K S, Pipe A L. Gender differences in predictors for long-term smoking cessation following physician advice and nicotine replacement therapy. Can J Public Health 2001; 92(6)418–422
- Benowitz N L. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008; 83(4)531–541
- Lerman C, Sheilds P G, Wileyto E P, et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002; 12(8)627–634